Therapeutic Application of Monoclonal Antibodies in Pancreatic Cancer: Advances, Challenges and Future Opportunities

SIMPLE SUMMARY: Pancreatic cancer is a leading cause of cancer death worldwide. In the majority of patients, cancers are diagnosed at advanced stages of disease and are resistant to current treatments. Therefore, more effective and less toxic therapeutic agents are urgently needed. Monoclonal antibo...

Descripción completa

Detalles Bibliográficos
Autores principales: Arias-Pinilla, Gustavo A., Modjtahedi, Helmout
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068268/
https://www.ncbi.nlm.nih.gov/pubmed/33917882
http://dx.doi.org/10.3390/cancers13081781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068268/
https://www.ncbi.nlm.nih.gov/pubmed/33917882
http://dx.doi.org/10.3390/cancers13081781

Ejemplares similares